Topics

      Case Review Form

      * Denotes required field.

      Injury Topic
      (Name of Drug or Device)

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of person injured
      (mm-dd-yyyy):

      Please describe your case:

      Date of Incident
      (mm-dd-yyyy):

      Other Info:

      No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

  • Archives

Defective Drugs

Prescription drugs should be safe if approved by the Food and Drug Administration. Unfortunately, many are not and the result could be debilitating injury or death for the patient. Same goes for over the counter products. This makes Americas Watchdog barking mad! Huge profits over safety is criminal.

The Latest Watchdog News for May 18, 2010


Pfizer Settles Neurontin Death Related Suit Before Trial

The world’s largest drugmaker, Pfizer, was set to defend itself today in court regarding a wrongful-death lawsuit alleging its Neurontin epilepsy medicine caused a retired minister to commit suicide two months after he began taking the drug for chronic pain, not epilepsy.

However, attorneys for the New York-based firm told a Nashville, Tennessee judge they resolved claims by the family of Richard Smith, but did not disclose the terms, said bloomberg.com. This is the second claim settlement that officials of a Pfizer unit knew the controversial drug posed a suicide risk but failed to alert doctors and patients.

Continue Reading »

The Latest Watchdog News for May 06, 2010


Positive News for Omniscan Patients

Omniscan plaintiffs were bolstered by U.S. District Judge Dan Polster’s recent decision regarding their lawsuits. In a 58-page procedural ruling, the judge restricted key parts of GE Healthcare’s case, but said most of the plaintiffs’ expert witnesses will be allowed to testify at trials.

GE Healthcare tried to exclude many plaintiff’ theories and witnesses from the proceedings, but Judge Polster rejected those attempts, including one that would have barred a plaintiff theory that Omniscan breaks down chemically, releasing a toxic metal that triggers the debilitating disease called nephrogenic systemic fibrosis (NSF). He will also allow testimony by two medical school professors that the company failed to properly warn radiologists concerning Omniscan.

Continue Reading »

The Latest Watchdog News for Apr 19, 2010


Omniscan Restriction Advised, But Not Heeded, Four Years Ago

Four years ago, GE Healthcare experts recommended limiting the use of their gadolinium contrast dye, Omniscan, after it was linked to nephrogenic systemic fibrosis (NSF), reveals ProPublica.

The decision was fueled by European reports that tied Omniscan to a likely crippling disease that is now known as NSF. Meeting details were exposed in a lawsuit’s unsealed order against the company, ProPublica said.

Continue Reading »

The Latest Watchdog News for Dec 09, 2009


Covidien’s Optimart and General Electric’s Omniscan Considered Risky

Thickening of the skin, organs and other tissues, broken bones, and difficulty moving the body are associated with a potentially fatal skin disease called nephrogenic systemic fibrosis (NSF).  Some gadolinium contrast dyes used for MRI scans could be the cause, according to a Food & Drug Administration (FDA) advisory panel.

Finally, the FDA is taking a stance on current data revealing that Covidien’s Optimart and General Electric’s Omniscan are risky for patients with severe kidney disease.  These products already carry a black box warning alerting doctors to avoid using them for those patients unless absolutely necessary.  Millions of people have been given these drugs to make MRI scans easier to read.

Continue Reading »